Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217782 · ClinicalTrials.gov registry record · NA
Pain in Juvenile Arthritis
A NA study of Juvenile Idiopathic Arthritis, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT07217782 is a NA study of Juvenile Idiopathic Arthritis that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 140 participants, below the 285-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07217782, a NA study of Juvenile Idiopathic Arthritis, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease in children. The main symptoms of JIA, which are often the primary focus of treatment, include joint swelling, stiffness, and tenderness. Additional symptoms can include malaise, fatigue, and pain. However, the exact mechanisms contributing to pain are not yet fully understood. Participants will complete a 2.5-hours study session. In the study session, psychophysical assessments of thermal and pressure stimuli will be performed. In addition, demographic, social, pubertal maturation, and behavioral and psychological factors will be collected via questionnaires. A saliva sample and/or blood draw may occur for the analysis of various immune factors and sex hormones. If a joint aspiration is done as part of their standard of care, we will request a sample of the synovial fluid for analyses of immune, hormonal and/or genetic factors. Participants will have the option to participate in additional optional follow-up study visits (every 3 months, up to 1 year) and to complete monthly surveys asking about their juvenile arthritis.
Conditions Studied
Interventions
- BEHAVIORAL Pressure pain thresholds (measured in kilopascal)
- BEHAVIORAL Cold pain tolerance (duration in seconds)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2025-09-15 |
| Est. Completion | 2035-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217782
The ClinicalTrials.gov registry entry for NCT07217782 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 285-participant average among 8 other Juvenile Idiopathic Arthritis trials with a reported enrollment target (51% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Juvenile Idiopathic Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Pressure pain thresholds (measured in kilopascal) is the first listed.
NCT07217782 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07217782 about?
NCT07217782 is a clinical study titled "Pain in Juvenile Arthritis". Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disease in children. The main symptoms of JIA, which are often the primary focus of treatment, include joint swelling, stiffness, and tenderness. Additional symptoms can include malaise, fatigue, and pain. However, the exact mechan...
What is the current status of trial NCT07217782?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2025-09-15. Estimated completion is 2035-09.
What conditions does trial NCT07217782 study?
This clinical trial studies the following conditions: Juvenile Idiopathic Arthritis.
What interventions are being tested in trial NCT07217782?
The interventions under investigation include: Pressure pain thresholds (measured in kilopascal) (BEHAVIORAL), Cold pain tolerance (duration in seconds) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07217782?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07217782 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Juvenile Idiopathic Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
RECRUITING · Phase 3
-
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
RECRUITING
-
An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis
ACTIVE NOT RECRUITING
-
Juvenile Idiopathic Arthritis (JIA) Registry
COMPLETED
-
Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis
COMPLETED · Phase 2
-
Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.